ENTITY

Molbio Diagnostics Limited (1788863D IN)

4
Analysis
Health Care • India
Molbio Diagnostics Limited is looking to raise about US$229m in its upcoming India IPO. The deal will be run by Kotak, IIFL, Jefferies and Motilal. Molbio Diagnostics is a healthcare technology company specializing in point-of-care molecular diagnostics. Its flagship product, the Truenat platform, is a portable, battery-operated PCR testing system used for the rapid detection of infectious and some non-communicable diseases. The company sells two main types of products: (1) hardware devices such as the Trueprep sample preparation unit and the Truelab PCR analyzers and (2) consumable test kits tailored to detect specific diseases. Truenat’s menu spans testing for more than 30 diseases, including tuberculosis, COVID-19, HIV, hepatitis B and C, HPV, malaria, and other infectious conditions. As of FY25, Molbio has deployed over 10,000 devices across more than 80 countries, though its revenue base remains primarily domestic, with ~80% of revenue from India and the remaining 20% from international markets such as Nigeria, Bangladesh, and Indonesia. The company operates five manufacturing facilities in India.
more
•23 Oct 2025 10:30

Molbio Diagnostics Limited Pre-IPO: Steady Growths in Topline And Profitability

​Molbio Diagnostics Limited plans to raise $229m in India IPO, known for point-of-care molecular diagnostics with Truenat PCR testing system.

Logo
303 Views
Share
•02 Sep 2025 14:12

Molbio Diagnostics Limited Pre-IPO Tearsheet

​Molbio Diagnostics Limited plans to raise $229m in India IPO, focusing on point-of-care molecular diagnostics with majority revenue from domestic...

Logo
383 Views
Share
bullish•Sany Heavy Industry
•27 Oct 2025 08:00

ECM Weekly (27 October 2025)- Sany, Seres, PonyAI, WeRide, CIG, JST, Lenskart, Horizon, CRB

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
637 Views
Share
bullish•Metaplanet
•08 Sep 2025 08:08

ECM Weekly (8 September 2025)- Metaplanet, Lifedrink, Koei, Hesai, Orion, Myungin, Hesai, Chery

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
702 Views
Share
x